Published in Cancer Weekly, February 5th, 2008
Addressing existing complementary product pipelines; Celgene Cellular Therapeutics and ImmuneRegen are exploring opportunities to jointly pursue U.S. government funding in support of their rapid wound healing applications.
CCT will perform testing of Homspera in order to evaluate the potential impact on cellular products in the company's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.